Cellectis
CLLS
36 hedge funds and large institutions have $27.6M invested in Cellectis in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 11 reducing their positions, and 5 closing their positions.
450% more call options, than puts
Call options by funds: $11K | Put options by funds: $2K
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
6% more funds holding
Funds holding: 34 → 36 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.15% less ownership
Funds ownership: 27.35% → 25.2% (-2.1%)
6% less capital invested
Capital invested by funds: $29.3M → $27.6M (-$1.7M)
73% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$57.5K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$5.69K |
| 3 |
LPL Financial
San Diego,
California
|
+$3.16K |
| 4 |
OC
Oppenheimer & Co
New York
|
+$2.93K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$2.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
-$1.33M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$424K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$250K |
| 4 |
Jane Street
New York
|
-$99.8K |
| 5 |
D.E. Shaw & Co
New York
|
-$83.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
26
Parallel Advisors
San Francisco,
California
| $984 | +$959 | +500 | New |
|
|
TWC
27
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $702 | – | – | – |
|
28
Russell Investments Group
London,
United Kingdom
| $193 | +$188 | +98 | New |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $89 | +$86 | +45 | New |
|
30
Barclays
London,
United Kingdom
| $55 | – | – | – |
|
|
EWA
31
EverSource Wealth Advisors
Birmingham,
Alabama
| $26 | – | – | – |
|
32
Bank of America
Charlotte,
North Carolina
| $4 | -$17.5K | -9,153 | -100% |
|
|
FGAM
33
Financial Gravity Asset Management
Lakeway,
Texas
| $2 | – | – | – |
|
|
CH
34
CVI Holdings
Wilmington,
Delaware
| – | -$250K | -129,434 | Closed |
|
|
35
Jane Street
New York
| – | -$99.8K | -50,522 | Closed |
|
36
Vontobel Holding
Zurich,
Switzerland
| – | -$57.9K | -30,000 | Closed |
|
|
OMC
37
Old Mission Capital
Chicago,
Illinois
| – | -$43.1K | -22,329 | Closed |
|
38
UBS Group
Zurich,
Switzerland
| – | -$637 | -330 | Closed |
|
39
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$17 | -9 | -14% |
|
|
BTI
40
Blue Trust Inc
Alpharetta,
Georgia
| – | +$92 | +48 | New |
|
CLLS Hedge Fund Activity: Q2 2023 in Review
36 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2023, worth a combined $27.6M — down 5.8% from $29.3M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CLLS positions and 5 closed out — a net gain of 2 holders — while 3 added to existing stakes and 11 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $57.5K. The largest seller was Principal Financial Group, cutting an estimated $1.33M.
- 36 institutional investors held Cellectis (CLLS) as of Q2 2023, up from 34 in Q1 2023.
- Funds reported $27.6M of Cellectis stock for Q2 2023, down 5.8% quarter-over-quarter.
- 7 funds opened new Cellectis positions in Q2 2023 and 5 closed out, a net change of +2 holders.
- The largest Cellectis buyer in Q2 2023 was Citadel Advisors, an estimated $57.5K added.
- The largest Cellectis seller in Q2 2023 was Principal Financial Group, an estimated $1.33M sold.
Based on aggregated 13F filings for Q2 2023.